Procter & Gamble reported strong quarterly results, exceeding estimates and raising their fiscal year EPS guidance. The successful integration of Gillette is contributing positively to sales and earnings, and management expressed confidence in continued growth driven by robust innovation and effective cost management. The upbeat outlook and raised guidance are likely to significantly boost the stock price in the short term.

[2]